Hyperacidity, GERD, and ulcers:
Indications for: Nizatidine Oral Solution
Active duodenal ulcer. Maintenance of healed duodenal ulcer. Benign gastric ulcer. Gastroesophageal reflux disease (GERD): including heartburn and erosive and ulcerative esophagitis.
Adult Dosage:
Active duodenal or benign gastric ulcer: 300mg daily at bedtime or 150mg twice daily, both for up to 8 weeks. Maintenance: 150mg daily at bedtime. GERD: 150mg twice daily for up to 12 weeks. Renal impairment (CrCl ≤50mL/min): reduce dose (see full labeling).
Children Dosage:
<12yrs: not established. Use oral soln. Erosive esophagitis, GERD (≥12yrs): 150mg twice daily for up to 8 weeks; max 300mg/day. Renal impairment (CrCl ≤50mL/min): reduce dose (see full labeling).
Nizatidine Oral Solution Warnings/Precautions:
Rule out malignant gastric ulceration. Renal impairment. Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
See Also:
Nizatidine Oral Solution Classification:
H2 blocker.
Nizatidine Oral Solution Interactions:
May elevate serum salicylate levels in high-dose aspirin patients.
Adverse Reactions:
Headache, anemia, diarrhea, dizziness, sweating, rhinitis, urticaria.
Note:
Formerly known under the brand name Axid.
How Supplied:
Contact supplier
